Pyxis Oncology is trading 5.09% up now at $3.92, extending recent volatility after gains of 19.81% on August 6 and 14.72% on August 3.
- No new company press release dated August 10 was identified; the latest investor-relations release is dated June 30.
- Recent bullish analyst coverage, including Wells Fargo’s Overweight rating and $12 target, may support sentiment, but available sources do not directly attribute the August 10 move to a specific catalyst.